P. Schoenfeld Asset Management (PSAM)’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History

P. Schoenfeld Asset Management (PSAM)’s Portfolio NKGN Stock Details NKGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-400,000	Closed	-$4.05M	–	120
2023 Q1	$4.05M	Hold	400,000	–	–	0.36%	48
2022 Q4	$3.98M	Hold	400,000	–	–	0.36%	54
2022 Q3	$3.9M	Hold	400,000	–	–	0.22%	83
2022 Q2	$3.88M	Hold	400,000	–	–	0.23%	100
2022 Q1	$3.88M	Buy	+400,000	New	+$3.88M	0.19%	129

Other funds holding NKGN

RCM

Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

SFM

Spartan Fund Management Toronto, Ontario, Canada $30M AUM 11.98% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

P. Schoenfeld Asset Management (PSAM)'s NKGN Position: Q2 2023 in Review

P. Schoenfeld Asset Management (PSAM) sold out of NKGen Biotech, Inc. Common Stock (NKGN) in Q2 2023, closing a stake of 400,000 shares — an estimated $4.05M sold.

P. Schoenfeld Asset Management (PSAM) first reported a position in NKGN in Q1 2022 and held it in 5 quarters. The position peaked at $4.05M in Q1 2023. 25 funds tracked by Wall St. Rank hold NKGN as of Q2 2023.

P. Schoenfeld Asset Management (PSAM) reported no remaining NKGen Biotech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
P. Schoenfeld Asset Management (PSAM) sold 400,000 NKGen Biotech, Inc. Common Stock shares in Q2 2023, an estimated $4.05M.
P. Schoenfeld Asset Management (PSAM) first reported a position in NKGen Biotech, Inc. Common Stock in Q1 2022 and held it in 5 quarters.
P. Schoenfeld Asset Management (PSAM)'s NKGen Biotech, Inc. Common Stock position peaked at $4.05M in Q1 2023.
25 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Common Stock as of Q2 2023.

Based on P. Schoenfeld Asset Management (PSAM)'s 13F filing for Q2 2023, filed 11 Aug 2023.